Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

201783 citationsReviewbronze Open Access

Authors

URL: http://www.clinicaltrials.gov. Unique identifier: NCT01994889.

Good health and well-being

Published in: Circulation Heart Failure

Volume 10, Issue 6

Field-Weighted Citation Impact: 3.81